Opportunities and Challenges in the Therapeutic and CDMO Markets

New Biologics and Advanced Therapies

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining the treatment landscape but also presenting new opportunities and challenges related to the drug development and manufacturing value chain.

With this backdrop, contract development and manufacturing organizations (CDMOs) play a pivotal role in enabling sponsor companies to bring groundbreaking therapies to patients.

Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth. Have a look at the analysis in the article “New Biologics and Advanced Therapies: Opportunities and Challenges in the Therapeutic and CDMO Markets” published in CHEManager.

Related news

Blog February 27, 2024
The 2024 Global Medtech Contract Manufacturing Report: Executive Summary
CDMO MedTech
News February 26, 2024
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
Alira Health announced the release of the 2024 Global Medtech Contract Manufacturing Report. This report offers a comprehensive analysis of trends in the global medtech contract manufacturing(...)
CDMO MedTech
Publications February 25, 2024
The 2024 Global Medtech Contract Manufacturing Report
Discover the trends in the world of medical device CDMOs and their meaning for the industry in 2024 and beyond.
CDMO MedTech
News February 7, 2024
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Pharma Transaction Advisory
Multimedia January 31, 2024
Medtech CDMO: Market and M&A Global Trends in 2024
This webinar replay investigates the current state of the global medtech CDMO industry and highlight Europe as a promising frontier for consolidation.
CDMO MedTech
News January 26, 2024
Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services
We are pleased to have been an advisor on Alcami’s acquisition of Pacific Pharmaceutical Services (PPS). Alira Health advised Alcami, a leading Contract Development Manufacturing(...)
Events January 22, 2024
Pharmapack Europe
Connect with our Drug Delivery Systems and CDMO experts Aude Ouensanga, Giulia Valsecchi, and Michal Raciborski on site at Pharmapack Europe.
CDMO Drug Delivery Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.